TD Asset Management Portfolio holdings
AUM
$124B
1-Year Est. Return
30.94%
This Fund
S&P 500
1 Year Est. Return
+30.94%
AUM
$123B
AUM Growth
+$5.97B
(+5.1%)
Holding
1,290
Top Buys
| 1 | +$680M | |
| 2 | +$338M | |
| 3 | +$233M | |
| 4 |
NVIDIA
NVDA
|
+$227M |
| 5 |
Cameco
CCJ
|
+$209M |
Top Sells
| 1 | +$1.77B | |
| 2 | +$269M | |
| 3 | +$265M | |
| 4 |
Eli Lilly
LLY
|
+$234M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$176M |
Sector Composition
| 1 | Technology | 22.87% |
| 2 | Financials | 22.27% |
| 3 | Industrials | 9.54% |
| 4 | Healthcare | 7.88% |
| 5 | Consumer Discretionary | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
EOG Resources
EOG
$63.9B
| $100M | 0.08% |
892,482
+662,539
|
|
||
202
Cencora
COR
$68.3B
| $99.6M | 0.08% |
318,541
+38,888
|
|
||
203
Comcast
CMCSA
$114B
| $99.2M | 0.08% |
3,156,212
+231,677
|
|
||
204
Invesco Senior Loan ETF
BKLN
$7.28B
| $96.4M | 0.08% |
4,607,575
-426
|
|
||
205
HEICO Corp
HEI
$45.8B
| $95.7M | 0.08% |
296,397
+1,795
|
|
||
206
CVS Health
CVS
$99.1B
| $95.2M | 0.08% |
1,263,369
+42,408
|
|
||
207
Eagle Materials
EXP
$7.31B
| $94.9M | 0.08% |
407,383
-179,405
|
|
||
208
Intel
INTC
$232B
| $93.6M | 0.08% |
2,791,114
+175,873
|
|
||
209
Cboe Global Markets
CBOE
$28.3B
| $93.4M | 0.08% |
380,880
-45,006
|
|
||
210
Pfizer
PFE
$156B
| $93M | 0.08% |
3,649,637
-28,692
|
|
||
211
Micron Technology
MU
$466B
| $92.4M | 0.08% |
552,236
-2,279
|
|
||
212
Donaldson
DCI
$12.7B
| $90.7M | 0.07% |
1,108,189
-48,389
|
|
||
213
Walt Disney
DIS
$181B
| $90.2M | 0.07% |
787,750
-31,261
|
|
||
214
Analog Devices
ADI
$162B
| $90.1M | 0.07% |
366,766
-19,751
|
|
||
215
argenx
ARGX
$51.6B
| $89.2M | 0.07% |
120,902
+860
|
|
||
216
Descartes Systems
DSGX
$5.57B
| $89.2M | 0.07% |
946,596
-42,628
|
|
||
217
RTX Corp
RTX
$270B
| $87.5M | 0.07% |
523,202
-15,938
|
|
||
218
Pan American Silver
PAAS
$23B
| $87.3M | 0.07% |
2,251,564
+274,591
|
|
||
219
Morgan Stanley
MS
$266B
| $86.8M | 0.07% |
545,941
-19,379
|
|
||
220
Cintas
CTAS
$78.4B
| $86.4M | 0.07% |
420,980
-314,716
|
|
||
221
Rollins
ROL
$28.2B
| $85.9M | 0.07% |
1,462,101
-45,482
|
|
||
222
Ferguson
FERG
$52.9B
| $85.5M | 0.07% |
380,792
-27,667
|
|
||
223
Vertex Pharmaceuticals
VRTX
$118B
| $85.2M | 0.07% |
217,539
-247,634
|
|
||
224
Vistra
VST
$55.3B
| $85M | 0.07% |
433,649
+55,851
|
|
||
225
AstraZeneca
AZN
$317B
| $83.6M | 0.07% |
1,089,612
+181,273
|
|